Guidant Will Move To Protect Atrial Fibrillation Patent Stable - CEO
This article was originally published in The Gray Sheet
Executive Summary
Guidant is likely to file suit against Medtronic after its anticipated launch of the Jewel AF dual-chamber implantable cardioverter defibrillator (ICD), claiming patent infringement of Guidant's portfolio of atrial fibrillation technology patents.
You may also be interested in...
St. Jude Photon ICD PMA Submission Expected By Mid-Year
St. Jude Medical says it expects to file a premarket approval application with FDA for the Photon DR dual-chamber implantable cardioverter defibrillator by mid-year.
St. Jude Photon ICD PMA Submission Expected By Mid-Year
St. Jude Medical says it expects to file a premarket approval application with FDA for the Photon DR dual-chamber implantable cardioverter defibrillator by mid-year.
Guidant Prizm Defibrillator Launches Jan. 31; Fourth Quarter Sales Up 16%
Shipments of Guidant's Ventak Prizm dual-chamber automatic implantable cardioverter defibrillator are anticipated to begin Jan. 31 following FDA approval via premarket approval application supplement, announced Jan. 24. A list price for the device is still being finalized.